5-Lipoxygenase inhibitors: a patent evaluation (WO2011161615)

By Buscató Estel.la   Proschak Ewgenij  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 843-846

Informa Healthcare

Access to resources Recommend Favorite

Pyrazolopyridines as inhibitors of the kinase LRRK2: a patent evaluation (WO2011141756)

By Deng Xianming   S. Gray Nathanael  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 709-713

Informa Healthcare

Access to resources Recommend Favorite

1,3-Oxazines as BACE1 and/or BACE2 inhibitors: a patent evaluation (WO2012156284)

By Gilbert Eric J  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 1069-1073

Informa Healthcare

Access to resources Recommend Favorite

Selective and reversible inhibitors of ubiquitin-specific protease 7: a patent evaluation (WO2013030218)

By Kessler Benedikt M  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 597-602

Informa Healthcare

Access to resources Recommend Favorite

Sialidase as a target for inhibitors of influenza virus replication

By Bethell R.C.   Smith P.W.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1501-1510

Informa Healthcare

Access to resources Recommend Favorite